Enterprise Value
-33.71M
Cash
189.4M
Avg Qtr Burn
-45.55M
Short % of Float
16.78%
Insider Ownership
18.19%
Institutional Own.
77.45%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Adintrevimab (ADG20) Details COVID-19 | Phase 3 Update | |
Phase 3 Update |